FibroGen Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
FibroGen (FGEN) Tops Q3 EPS by 55c; Reports Cash and Cash Equivalents of $665.0M
November 9, 2021 4:29 PM ESTFibroGen (NASDAQ: FGEN) reported Q3 EPS of $0.54, $0.55 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $156 million versus the consensus estimate of $143.46 million.
For earnings history and earnings-related data on FibroGen (FGEN) click here.
... More


